Form 4: Erasca Inc. Executive Ebun Garner Reports Stock and Option Transactions
SEC Form 4 Filing
Ebun Garner, General Counsel & Corp. Sec. of Erasca, Inc., reports the acquisition of common stock through the company's employee stock purchase plan and the grant of stock options.
Summary
- Ebun Garner, General Counsel & Corp. Sec. of Erasca, Inc., filed a Form 4 detailing changes in beneficial ownership.
- Garner acquired common stock through the company's 2021 Employee Stock Purchase Plan on June 14, 2024, and December 13, 2024, at a price of $1.564 per share.
- The number of shares acquired on each date was 5,715 and 5,731 respectively.
- Following these transactions, Garner beneficially owns 21,174 shares of common stock.
- Garner was also granted a stock option to purchase 700,000 shares of common stock at an exercise price of $1.76, which vests monthly starting February 1, 2025, over 48 months.
- The options expire on February 2, 2035.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The insider is increasing their stake in the company, which is generally a good sign. The stock options provide long-term incentives.
Positives
- The acquisition of shares through the employee stock purchase plan indicates Garner's investment in the company's future.
- The grant of stock options aligns Garner's interests with those of the shareholders, incentivizing her to contribute to the company's success.
Future Outlook
The stock options vest monthly starting February 1, 2025, subject to continuous service, indicating a long-term incentive for the reporting person.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates that a key executive is increasing their stake in the company through stock purchases and option grants.
Comparison to Industry Standards
- Employee stock purchase plans and stock option grants are common compensation practices in the biotechnology industry, used to attract and retain talent.
- The vesting schedule of the options (monthly over 48 months) is a typical arrangement to incentivize long-term commitment.
- The specific terms of the plan and option grants would need to be compared to those of peer companies to assess their competitiveness.
Stakeholder Impact
- The insider's transactions may signal confidence in the company's prospects to shareholders.
- The stock option grants incentivize the executive to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Purchase of common stock under the Company's 2021 Employee Stock Purchase Plan |
| 12/13/2024 | Purchase of common stock under the Company's 2021 Employee Stock Purchase Plan |
| 02/03/2025 | Date of earliest transaction (stock option grant) |
| 02/01/2025 | Vesting start date for stock options |
| 02/02/2035 | Expiration date for stock options |
| 02/05/2025 | Date of Form 4 filing |
Keywords
Form 4, Beneficial Ownership, Stock Options, Employee Stock Purchase Plan, Erasca, Garner, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.